Joseph Walter Vazzano
Chief Financial OfficerMr. Joseph Walter Vazzano, also known as Joe, CPA, served as Chief Financial Officer at Abeona Therapeutics, Inc. since March 14, 2022. He Joined Abeona Therapeutics Inc. since March 14, 2022. He was an Independent Director of Allarity Therapeutics, Inc. since August 01, 2023 until June 30, 2025. Mr. Vazzano served as Chief Financial Officer at Avenue Therapeutics, Inc., since February 08, 2019 until January 14, 2022. Mr. Vazzano served as Company Secretary at Avenue Therapeutics, Inc until January 14, 2022 and served as its Principal Financial Officer. Mr. Vazzano had been Vice President of Finance and Accounting and Controller at Avenue Therapeutics, Inc. since August 15, 2017 till February 08, 2019. Mr. Vazzano joined Intercept Pharmaceuticals, Inc. in 2016, where he served as Assistant Corporate Controller from October 2016 to July 2017 and oversaw the expansion of the finance and accounting department during its transition from development-stage to a fully integrated commercial organization. Prior to Intercept, Mr. Vazzano served as Assistant Controller at Pernix Therapeutics Inc, where he successfully built an accounting and finance team after a corporate restructuring. From 2010 to 2015, Mr. Vazzano held roles of increasing responsibility in finance and accounting at NPS Pharmaceuticals, a publicly traded biotechnology company acquired by Shire Pharmaceuticals and was a Senior Auditor at KPMG, LLP. He has extensive financial and accounting expertise. Mr. Vazzano holds a B.S. in accounting from Lehigh University in Bethlehem, PA and is a certified public accountant in New Jersey.
公司职务
- 公司名称Abeona Therapeutics Inc.股票代码ABEO职务Chief Financial Officer共事同僚
- VSVishwas SeshadriPresident, CEO & Director
- FLFaith L. CharlesIndependent Interim Chairman of the Board
- BMBrendan M. O’MalleyChief Legal Officer
- BKBrian KevanyChief Technical & Scientific Officer
- GGGregory GinVice President of Investor Relations & Corporate Communications
- MJMark J. AlvinoIndependent Director
- KAKeith Alan GoldanIndependent Director
- SGSteven GrayMember of Scientific Advisory Board
